Patent · US Expired

Erythropoietin solution formulation

US7468351B2 · kind B2 · utility

0Cited by

6References

13Claims

0Family size

Assignee

Bioggnerix AG · DE

Inventors

Stefan Arnold · Munster, DE
Okke Franssen · Utrecht, NL
Albert Mekking · Woerden, NL

Key dates

Filing date	Dec 1, 2004
Grant date	Dec 23, 2008
Priority date	—
Expiry date	Dec 22, 2024

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A stable pharmaceutical formulation of erythropoietin is disclosed which contains tris-(hydrox-ymethyl)-aminomethane as stabilizer, whereby the formulation does not contain amino acids or human serumalbumin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.